These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29756486)

  • 1. Osteonectin as a screening marker for pancreatic cancer: A prospective study.
    Papapanagiotou A; Sgourakis G; Karkoulias K; Raptis D; Parkin E; Brotzakis P; Panchal S; Papavassiliou AG
    J Int Med Res; 2018 Jul; 46(7):2769-2779. PubMed ID: 29756486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Prediction of Acute Biliary Pancreatitis Outcome on Admission.
    Papapanagiotou A; Sgourakis G; Peristeraki S; Raptis D; Karkoulias K; Tezas S; Patel P; Papavassiliou AG
    Pancreas; 2018 Apr; 47(4):454-458. PubMed ID: 29517633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study.
    Zubarik R; Gordon SR; Lidofsky SD; Anderson SR; Pipas JM; Badger G; Ganguly E; Vecchio J
    Gastrointest Endosc; 2011 Jul; 74(1):87-95. PubMed ID: 21704809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
    Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
    Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
    Dutta SK; Girotra M; Singla M; Dutta A; Otis Stephen F; Nair PP; Merchant NB
    Pancreas; 2012 May; 41(4):530-4. PubMed ID: 22158074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
    Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
    Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer.
    Vasiliades G; Kopanakis N; Vasiloglou M; Zografos G; Margaris H; Masselou K; Kokosi E; Liakakos T
    Int J Biol Markers; 2012 Oct; 27(3):e186-94. PubMed ID: 22865301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen.
    Ward DG; Wei W; Buckels J; Taha AM; Hegab B; Tariciotti L; Salih R; Qi YQ; Martin A; Johnson PJ
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1358-63. PubMed ID: 20555269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neurotensin as a novel biomarker in the endoscopic screening of high-risk population for developing colorectal neoplasia.
    Kontovounisios C; Qiu S; Rasheed S; Darzi A; Tekkis P
    Updates Surg; 2017 Sep; 69(3):397-402. PubMed ID: 28560510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum des-gamma-carboxyprothrombin in patients with pancreatic head adenocarcinoma.
    Kemik AS; Kemik O; Purisa S; Tuzun S
    Bratisl Lek Listy; 2011; 112(10):552-4. PubMed ID: 21954538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
    Murakami M; Nagai Y; Tenjin A; Tanaka Y
    Endocr J; 2018 Jun; 65(6):639-643. PubMed ID: 29643268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fatty acid synthase as a marker of pancreatic neoplasia.
    Walter K; Hong SM; Nyhan S; Canto M; Fedarko N; Klein A; Griffith M; Omura N; Medghalchi S; Kuhajda F; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2380-5. PubMed ID: 19723916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.
    Baraniskin A; Nöpel-Dünnebacke S; Ahrens M; Jensen SG; Zöllner H; Maghnouj A; Wos A; Mayerle J; Munding J; Kost D; Reinacher-Schick A; Liffers S; Schroers R; Chromik AM; Meyer HE; Uhl W; Klein-Scory S; Weiss FU; Stephan C; Schwarte-Waldhoff I; Lerch MM; Tannapfel A; Schmiegel W; Andersen CL; Hahn SA
    Int J Cancer; 2013 Jan; 132(2):E48-57. PubMed ID: 22907602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
    Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DR-70 as a novel diagnostic biomarker for gastric cancer.
    Arhan M; Yılmaz H; Önal İK; Kocabıyık M; Erdal H; İbiş M
    Turk J Gastroenterol; 2015 Nov; 26(6):480-3. PubMed ID: 26575041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study.
    Malesci A; Montorsi M; Mariani A; Santambrogio R; Bonato C; Bissi O; Tacconi M; Wizemann G; Spina G
    Pancreas; 1992; 7(4):497-502. PubMed ID: 1641392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.